A Phase 2, Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy01/21/2020 - 01/20/2023 (PI)
Bristol-Myers Bristol-Myers
Toll-like receptor Induced pathways in lupus nephritis07/01/2016 - 12/31/2017 (PI)
National Kidney Fdtn